ArticleBMC pharmacology & toxicology2018

Dihydroisotanshinone I combined with radiation inhibits the migration ability of prostate cancer cells through DNA damage and CCL2 pathway.

I-Yun Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.